Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01018901 · ClinicalTrials.gov registry record · NA
Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01018901 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 2 participants.
The verdict
NCT01018901, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about survivors of prostate cancer and their partners may help doctors learn more about the goals for sexual functioning after cancer treatment. PURPOSE: This clinical trial is studying the goals of sexual functioning in prostate cancer survivors and their partners after cancer treatment.
Interventions
- OTHER Survey Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-01 |
| Est. Completion | 2013-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01018901
The ClinicalTrials.gov registry entry for NCT01018901 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Survey Administration is the first listed.
NCT01018901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01018901 about?
NCT01018901 is a clinical study titled "Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment". RATIONALE: Gathering information about survivors of prostate cancer and their partners may help doctors learn more about the goals for sexual functioning after cancer treatment. PURPOSE: This clinical trial is studying the goals of sexual functioning in prostate cancer survivors and their partners a...
What is the current status of trial NCT01018901?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2009-01. Estimated completion is 2013-12-31.
What interventions are being tested in trial NCT01018901?
The interventions under investigation include: Survey Administration (OTHER).
Who is sponsoring clinical trial NCT01018901?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.